2-({[3-(ethoxycarbonyl)-4,5,6,7-tetrafluorobenzo[b]furan-2-yl]methyl}sulphinyl)pyridinium-1-olate

Catalog No. :
ACXSKB761
CAS No. :
256425-31-7
Molecular Formula :
C17H11F4NO5S
Molecular Weight :
417.34

IUPAC Name:2-(((3-(ethoxycarbonyl)-4,5,6,7-tetrafluorobenzofuran-2-yl)methyl)sulfinyl)pyridine 1-oxide

2-({[3-(ethoxycarbonyl)-4,5,6,7-tetrafluorobenzo[b]furan-2-yl]methyl}sulphinyl)pyridinium-1-olate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-({[3-(ethoxycarbonyl)-4,5,6,7-tetrafluorobenzo[b]furan-2-yl]methyl}sulphinyl)pyridinium-1-olate
IUPAC Name2-(((3-(ethoxycarbonyl)-4,5,6,7-tetrafluorobenzofuran-2-yl)methyl)sulfinyl)pyridine 1-oxide
Molecular FormulaC17H11F4NO5S
Molecular Weight417.34
SMILES[O-][N+]1=CC=CC=C1S(CC2=C(C(OCC)=O)C3=C(F)C(F)=C(F)C(F)=C3O2)=O
InChI KeyXKLORINYMQPPGB-UHFFFAOYSA-N
Synonym3-Benzofurancarboxylic acid, 4,5,6,7-tetrafluoro-2-[[(1-oxido-2-pyridinyl)sulfinyl]methyl]-, ethyl ester
CAS No.256425-31-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXSKB761 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXSKB761 route product structure diagram
    ACXSKB761256425-31-7
Inquiry

2. ACXSKB761 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXSKB761 route product structure diagram
    ACXSKB761256425-31-7
Inquiry

Comments (0)